David Stanton
Stock Analyst at Jefferies
(4.08)
# 1,715
Out of 5,134 analysts
252
Total ratings
43.7%
Success rate
9.9%
Average return
Main Sectors:
Stocks Rated by David Stanton
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASX: IDX Integral Diagnostics Limited | Reiterated: Buy | $3.30 → $2.90 | $1.65 | +75.76% | 12 | Oct 29, 2026 | |
| ASX: SIG Sigma Healthcare Limited | Reiterated: Buy | $3.20 → $3.15 | $2.90 | +8.62% | 19 | Oct 21, 2026 | |
| ASX: TLX Telix Pharmaceuticals Limited | Reiterated: Buy | $32.00 → $31.50 | $13.39 | +135.25% | 27 | Oct 21, 2026 | |
| ASX: PME Pro Medicus Limited | Reiterated: Hold | $196.95 → $199.00 | $201.66 | -1.32% | 7 | Oct 20, 2026 | |
| ASX: MSB Mesoblast Limited | Reiterated: Buy | $2.90 → $2.80 | $1.89 | +48.54% | 18 | Oct 16, 2026 | |
| ASX: RHC Ramsay Health Care Limited | Reiterated: Hold | $48.50 → $49.85 | $54.95 | -9.28% | 14 | Oct 13, 2026 | |
| ASX: CSL CSL Limited | Reiterated: Hold | $146.50 → $161.50 | $202.52 | -20.25% | 26 | Oct 6, 2026 | |
| ASX: HLS Healius Limited | Reiterated: Hold | $0.41 → $0.44 | $0.58 | -24.14% | 19 | Sep 25, 2026 | |
| ASX: IMM Immutep Limited | Upgraded: Buy | $0.04 → $0.08 | $0.02 | +233.33% | 9 | Sep 15, 2026 | |
| ASX: MVF Monash IVF Group Limited | Reiterated: Buy | $0.83 → $0.80 | $0.73 | +9.59% | 12 | Sep 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40.80 → $39.30 | $7.59 | +417.79% | 12 | Aug 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $29.40 → $28.90 | $22.98 | +25.76% | 19 | Aug 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $128.40 → $144.75 | $150.83 | -4.03% | 20 | Aug 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $23.00 → $21.00 | $19.98 | +5.11% | 22 | Aug 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5.00 → $5.60 | $1.83 | +206.85% | 12 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $12.45 | n/a | 1 | Dec 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $13.39 | n/a | 3 | Apr 8, 2021 |
Integral Diagnostics Limited
Oct 29, 2026
Reiterated: Buy
Price Target: $3.30 → $2.90
Current: $1.65
Upside: +75.76%
Sigma Healthcare Limited
Oct 21, 2026
Reiterated: Buy
Price Target: $3.20 → $3.15
Current: $2.90
Upside: +8.62%
Telix Pharmaceuticals Limited
Oct 21, 2026
Reiterated: Buy
Price Target: $32.00 → $31.50
Current: $13.39
Upside: +135.25%
Pro Medicus Limited
Oct 20, 2026
Reiterated: Hold
Price Target: $196.95 → $199.00
Current: $201.66
Upside: -1.32%
Mesoblast Limited
Oct 16, 2026
Reiterated: Buy
Price Target: $2.90 → $2.80
Current: $1.89
Upside: +48.54%
Ramsay Health Care Limited
Oct 13, 2026
Reiterated: Hold
Price Target: $48.50 → $49.85
Current: $54.95
Upside: -9.28%
CSL Limited
Oct 6, 2026
Reiterated: Hold
Price Target: $146.50 → $161.50
Current: $202.52
Upside: -20.25%
Healius Limited
Sep 25, 2026
Reiterated: Hold
Price Target: $0.41 → $0.44
Current: $0.58
Upside: -24.14%
Immutep Limited
Sep 15, 2026
Upgraded: Buy
Price Target: $0.04 → $0.08
Current: $0.02
Upside: +233.33%
Monash IVF Group Limited
Sep 1, 2026
Reiterated: Buy
Price Target: $0.83 → $0.80
Current: $0.73
Upside: +9.59%
Aug 30, 2026
Reiterated: Buy
Price Target: $40.80 → $39.30
Current: $7.59
Upside: +417.79%
Aug 27, 2026
Reiterated: Buy
Price Target: $29.40 → $28.90
Current: $22.98
Upside: +25.76%
Aug 20, 2026
Reiterated: Hold
Price Target: $128.40 → $144.75
Current: $150.83
Upside: -4.03%
Aug 20, 2026
Reiterated: Hold
Price Target: $23.00 → $21.00
Current: $19.98
Upside: +5.11%
Jul 28, 2026
Reiterated: Buy
Price Target: $5.00 → $5.60
Current: $1.83
Upside: +206.85%
Dec 6, 2022
Downgraded: Hold
Price Target: n/a
Current: $12.45
Upside: n/a
Apr 8, 2021
Downgraded: Hold
Price Target: n/a
Current: $13.39
Upside: n/a